New Insights into TETs in Psychiatric Disorders

Int J Mol Sci. 2022 Apr 28;23(9):4909. doi: 10.3390/ijms23094909.

Abstract

Psychiatric disorders are complex and heterogeneous disorders arising from the interaction of multiple factors based on neurobiology, genetics, culture, and life experience. Increasing evidence indicates that sustained abnormalities are maintained by epigenetic modifications in specific brain regions. Over the past decade, the critical, non-redundant roles of the ten-eleven translocation (TET) family of dioxygenase enzymes have been identified in the brain during developmental and postnatal stages. Specifically, TET-mediated active demethylation, involving the iterative oxidation of 5-methylcytosine to 5-hydroxymethylcytosine and subsequent oxidative derivatives, is dynamically regulated in response to environmental stimuli such as neuronal activity, learning and memory processes, and stressor exposure. Here, we review the progress of studies designed to provide a better understanding of how profiles of TET proteins and 5hmC are powerful mechanisms by which to explain neuronal plasticity and long-term behaviors, and impact transcriptional programs operative in the brain that contribute to psychiatric disorders.

Keywords: 5-hydroxymethylcytosine; TET enzyme; psychiatric disorder.

Publication types

  • Review

MeSH terms

  • 5-Methylcytosine / metabolism
  • DNA Methylation
  • Dioxygenases* / genetics
  • Epigenesis, Genetic
  • Humans
  • Mental Disorders* / genetics
  • Mental Disorders* / metabolism
  • Neuronal Plasticity / genetics

Substances

  • 5-Methylcytosine
  • Dioxygenases